•The TruHealth Cancer Screen 360 offers early cancer detection through tumor markers
•Metropolis Healthcare aims to enhance preventive healthcare in India
•The initiative focuses on empowering individuals with actionable information to improve health
The TruHealth Cancer Screen 360 Male and Female Profiles are scientifically designed to deliver early insight, empowering both clinicians and individuals with valuable, actionable information.

The TruHealth Cancer Screen 360 comprises tumour markers, hereditary cancer risk assessment, and gender-specific screening modules like PSA for prostate cancer in men and HPV self-sampling for cervical cancer in women. Aiming to meet the increasing burden of cancer and fill diagnostic gaps, the panel provides a multi-layered, evidence-based solution to identify early indicators of prevalent cancers in both men and women.

Surendran Chemmenkottil, CEO, Metropolis Healthcare, stated, "The launch of TruHealth Cancer Screen 360 Male and Female Profiles is a testament to our unflinching commitment to building preventive healthcare in India. By empowering individuals with timely and accurate diagnostic tools, we hope to enable them to take control of their health. Early detection is the key to lowering the incidence of late-stage cancer, enhancing outcomes, and saving lives.

This initiative also aligns with our strategic emphasis on building Metropolis' presence in oncology diagnostics a rapidly growing area in healthcare. We continue to be committed to making advanced diagnostics affordable and accessible across urban and non-urban geographies.

Dr Kirti Chadha, Senior Oncopathologist and Chief Scientific and Innovation Officer at Metropolis Healthcare said, "The TruHealth Cancer Screen 360 has been designed as an evidence-based, all-encompassing solution that moves beyond general wellness testing. With an embracing range of biomarkers and hereditary risk factors, it enables early detection of cancer risks much before symptoms arise. This strategy improves clinical decision-making and empowers individuals with actionable information, closing the loop between symptomless disease development and appropriate medical intervention."